All lobbying filings

THE KPM GROUP DC LLC

Lobbying for INOZYME PHARMA · Treatments for PPi-Adenosine Pathway, ENPP1 Deficiency, ABCC6 Deficiency, & calciphylaxis.

Filing Registration

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · posted Jul 15, 2025

Official filing document

Bills named in this filing 5

HR 1262
Mikaela Naylon Give Kids a Chance Act
HR 946
ORPHAN Cures Act
HR 1414
Cameron’s Law
HR 1532
Scientific EXPERT Act of 2025
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…

Lobbying activity 1

Pharmacy

FDA modernization H.R.1262 - Give Kids a Chance Act Trump administration impact on staffing at HHS and FDA Newborn screening Inflation Reduction Act (IRA) H.R.946 - ORPHAN Cures Act H.R. 1414 - Cameron's Law H.R.1532 - Scientific External Process for Educated Review of Therapeutics (EXPERT) Act H.R.1492 - Ensuring Pathways to Innovative Cures (EPIC) Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.